LANXESS has reported a challenging third quarter of 2025 as persistent global economic weakness and geopolitical uncertainty weighed heavily on performance. Revenue declined 16.3 per cent to EUR 1.34 billion, while EBITDA pre-exceptionals fell 27.7 per cent to EUR 125 million, largely due to subdued demand, lower volumes and the absence of contributions from the divested Urethane Systems business. Currency effects also affected earnings. The EBITDA margin pre-exceptionals stood at 9.3 per cent, down from 10.8 per cent a year ago.

The company has updated its full-year 2025 guidance, now expecting EBITDA pre-exceptionals to be at the lower end of the earlier projected range of EUR 520–580 million. LANXESS plans further cost optimisation measures worth around EUR 100 million, building on its ongoing “FORWARD!” programme and additional production network efficiencies.

Net financial debt remained stable at EUR 2.07 billion due to strict cash discipline. Segment-wise, Consumer Protection saw a modest EBITDA improvement despite lower sales, while Specialty Additives and Advanced Intermediates faced significant declines due to weak demand, price pressure and reduced capacity utilisation.

CEO Matthias Zachert emphasised continued focus on cost control, structural efficiencies and market positioning, while urging stronger political support to maintain the competitiveness of Europe’s chemical industry.